powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1558650713
Daniel Lachant
D.O.
PRACTICE
GASTROINTESTINAL GROUP
See all providers at this practice →
Pulmonary Disease
Rochester,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$6K
Payment records
21
By payment type
Consulting Fee
$4K
Travel and Lodging
$1K
Food and Beverage
$1K
Top paying entities
Consulting Fee
$4K
Travel and Lodging
$1K
Food and Beverage
$1K
QUALITY · MIPS · 2024
Final MIPS score
94.2
Quality
67.5
Cost
79.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.81%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
1,845
Beneficiaries
—
Total drug cost
$10.7M
Distinct drugs
15
Brand share
21.1%
Top prescribed drugs
Tadalafil
666 claims
Ambrisentan
516 claims
Torsemide
101 claims
Treprostinil
97 claims
Riociguat
89 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
52
Unique beneficiaries
—
Total services
85
Distinct HCPCS
2
Medicare payment
$4K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 811 Pulmonary Disease providers in NY — bottom quintile (cohort median 790).
